A Study of VET3-TGI in Patients With Solid Tumors

Clinical trial NCT06444815 · RECRUITING

Trial details

NCT number: NCT06444815
Sponsor: KaliVir Immunotherapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Microsatellite Stable Colorectal Cancer Head and Neck Squamous Cell Carcinoma Cervical Cancer Kidney Cancer Renal Cell Carcinoma Melanoma Stage IV Merkel Cell Carcinoma of Skin Mesothelioma Non-small Cell Lung Cancer Cutaneous Squamous Cell Carcinoma (CSCC)Urothelial Carcinoma Bladder

Start date: 2024-09-16
Primary completion: 2027-09-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.